Novo Nordisk’s Ozempic shortage expected to continue into Q4, Health News, ET HealthWorld
Bengaluru: Novo Nordisk said the shortage of lower strengths of its diabetes drug Ozempic has deteriorated, with intermittent shortages for all strengths expected into the final quarter of 2024 due…